Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy

23 Oct 2017

Abstract excerpt

PURPOSE: DNA mismatch repair (MMR) is a highly conserved biological pathway that plays a key role in maintaining genomic stability. MMR has been reported as a prognostic marker in certain cancers; however, the results are controversial. Therefore, identification of the prognostic value of MMR genes in ovarian cancer based on a large sample size is pivotal. METHODS: In the current study, we systemically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Ferroptosis and cancer prognosis
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29063235
DOI: 10.1007/s00404-017-4563-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapyPMID 29063235Read ↗

Updated evaluation of clinicopathologic landscape in histopathologic subtypes of endometrial carcinoma with MMR gene mutationSemantic proximity Read ↗

Updated evaluation of clinicopathologic landscape in histopathologic subtypes of endometrial carcinoma with MMR gene mutationSemantic proximity Read ↗

Mismatch Repair Gene Deficiency in Ovarian Cancer: A Clinicopathological Analysis of MLH1, PMS2, MSH2, and MSH6 Mutations Across Histological Subtypes.Semantic proximity Read ↗

Biomarkers for chemotherapy and drug resistance in the mismatch repair pathwaySemantic proximity Read ↗

Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancerSemantic proximity Read ↗

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural MesotheliomaSemantic proximity Read ↗

hMSH2 Coordinated with the Expression of E2F1 Promotes Platinum Response in Epithelial Ovarian CancerSemantic proximity Read ↗

Prognostic Significance of TM4SF1 and DDR1 Expression in Ovarian CancerSemantic proximity Read ↗

Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients.Semantic proximity Read ↗

Correlation of MSH3 polymorphisms with response and survival in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.Semantic proximity Read ↗

ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancersSemantic proximity Read ↗

Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.